Aptamer and Timser partner to deliver world’s first blood test for cervical cancer

  • Post author:
  • Post category:uncategorized

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has signed an agreement with Timser Group, a pharmaceutical company focused on women’s health, with a deal value of up to £465,000.